Wolverine Trading’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-117,600
Closed -$3.49M 5509
2023
Q4
$3.49M Buy
+117,600
New +$2.34M ﹤0.01% 1311
2020
Q2
Sell
-17,100
Closed -$61K 5420
2020
Q1
$61K Buy
17,100
+6,200
+57% +$27.1K ﹤0.01% 4197
2019
Q4
$55K Sell
10,900
-19,000
-64% -$64.5K ﹤0.01% 4445
2019
Q3
$81K Sell
29,900
-2,900
-9% -$7.7K ﹤0.01% 3926
2019
Q2
$71K Sell
32,800
-74,200
-69% -$175K ﹤0.01% 4117
2019
Q1
$290K Buy
107,000
+79,200
+285% +$343K ﹤0.01% 3397
2018
Q4
$125K Sell
27,800
-10,900
-28% -$66.1K ﹤0.01% 3897
2018
Q3
$366K Buy
+38,700
New +$372K ﹤0.01% 3491
2018
Q1
Sell
-28,500
Closed -$183K 6015
2017
Q4
$183K Sell
28,500
-16,200
-36% -$99.9K ﹤0.01% 4214
2017
Q3
$342K Buy
44,700
+19,000
+74% +$126K ﹤0.01% 3087
2017
Q2
$186K Buy
+25,700
New +$118K ﹤0.01% 3638
2017
Q1
Sell
-25,300
Closed -$52K 5205
2016
Q4
$52K Buy
25,300
+4,600
+22% +$9.23K ﹤0.01% 4201
2016
Q3
$55K Buy
+20,700
New +$60.2K ﹤0.01% 4382

Other funds holding IMGN

Wolverine Trading's IMGN Position: Q1 2024 in Review

Wolverine Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 9,166 shares — an estimated $272K sold.

Wolverine Trading first reported a position in IMGN in Q2 2017 and held it in 12 quarters. The position peaked at $398K in Q3 2017. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Wolverine Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Wolverine Trading sold 9,166 Immunogen Inc shares in Q1 2024, an estimated $272K.
  • Wolverine Trading first reported a position in Immunogen Inc in Q2 2017 and held it in 12 quarters.
  • Wolverine Trading's Immunogen Inc position peaked at $398K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Wolverine Trading's 13F filing for Q1 2024, filed 15 May 2024.